Welcome to the 2021 IGCS Meeting Program Scheduling
The meeting will officially run on Central European Time (Rome time-zone, GMT+2)
To convert the meeting times to your local time Click Here
Hall 1
Session Type
Master Session
Room
Hall 1
Date
09/02/2021
Chair(s)
Session Description
Session Description: This Ovarian Cancer Master session will focus on critical elements of ovarian cancer management including novel surgical approaches, current and future therapeutic landscape, and diagnostic/predictive biomarkers. Moreover, real-world implementation of ovarian cancer treatments, genetic and tumor testing, as well as access to care will be identified through an audience response system. The opportunity to share our experiences through a highly interactive virtual and in-person hybrid session will inform our panel discussions with leading experts in the field. By learning together, we can identify solutions to overcome barriers to care, strive for health equity, and improve lives for those with ovarian cancer.
Master Session
Introduction of Session Chairs and Opening Talk Global overview of Ovarian cancer (ID 751)
Lecture Time
12:00 PM - 12:10 PM
Presenter
Master Session
Cutting Edge of Innovation: Surgery (ID 752)
Lecture Time
12:10 PM - 12:10 PM
Presenter
Master Session
Novel Surgical strategies and current major trial updates in ovarian cancer (ID 753)
Master Session
Global challenges of the implementation of surgery for advanced disease (ID 754)
Lecture Time
12:20 PM - 12:30 PM
Presenter
Authors
Master Session
Oncologic and reproductive aspects of fertility sparing surgery in epithelial and non epithelial subtypes (ID 755)
Lecture Time
12:30 PM - 12:40 PM
Master Session
Panel Discussion and Q&A (ID 756)
Lecture Time
12:40 PM - 12:55 PM
Master Session
Move over Chemotherapy: Exploring Systemic Therapeutic Options in Ovarian Cancer (ID 1010)
Lecture Time
12:55 PM - 12:55 PM
Master Session
Session introduction & survey (ID 1011)
Lecture Time
12:55 PM - 01:00 PM
Master Session
Beyond PARPi Progression - What now? (ID 1012)
Lecture Time
01:00 PM - 01:10 PM
Presenter
Master Session
Exploring Non-conventional Therapeutic Options (ID 1013)
Master Session
Real-World Challenges Accessing Novel Therapeutics (ID 1014)
Lecture Time
01:20 PM - 01:30 PM
Presenter
Master Session
Panel Discussion and Q&A (ID 1008)
Lecture Time
01:30 PM - 01:40 PM
Master Session
Role of prognostic and predictive Biomarkers in Ovarian cancer (ID 1004)
Master Session
Biomarkers to direct surgical treatment - current landscape PREDICT OPTIMIZE OUTCOME (ID 1005)
Lecture Time
01:40 PM - 01:50 PM
Presenter
Authors
Master Session
Biomarkers to direct systemic treatment - Current landscape ESMO GUIDELINES (ID 1006)
Lecture Time
01:50 PM - 02:00 PM
Presenter
Authors
Master Session
Biomarker future directions and clinical trials (ID 1007)
Lecture Time
02:00 PM - 02:10 PM
Presenter
Authors
Master Session
Panel Discussion and Q&A (ID 1015)
Lecture Time
02:10 PM - 02:25 PM
Master Session
Closing Comments (ID 1009)
Lecture Time
02:25 PM - 02:30 PM
Presenter